CLNN.NASDAQClene INC

Form 4: Clene Inc. Director Alison Mosca Reports Acquisition of Shares and Warrants

Sentiment:

SEC Form 4 Filing


๐Ÿ“‹All filings for Clene INC

Alison Mosca, a director of Clene Inc., reported acquiring shares and warrants, along with adjustments to previously held shares due to a reverse stock split.

Summary

  • On September 30, 2024, Alison Mosca, a director of Clene Inc., reported acquiring 159,134 shares of common stock at $4.588 per share.
  • Mosca also acquired 159,134 common stock purchase warrants with an exercise price of $4.82, exercisable from October 1, 2024, to October 1, 2029.
  • The report reflects adjustments to Mosca's holdings due to a 1-for-20 reverse stock split that occurred on July 11, 2024.
  • The reverse stock split reduced Mosca's directly owned shares from 39,476 to 1,973 and indirectly owned shares through various entities.
  • Mosca's indirect ownership includes shares held by Kensington Clene 2021, LLC (321,052 shares), Kensington Investments, L.P. (150,333 shares), and the Robert C. Gay 1998 Family Trust (72,997 shares).
  • Mosca disclaims beneficial ownership of shares held by Kensington Clene 2021, LLC and Kensington Investments, L.P. for which she does not have a pecuniary or profits interest, and the Robert C. Gay 1998 Family Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While a director increasing their stake is generally positive, the reverse stock split and the disclaimer of beneficial ownership in some shares held through entities temper the overall sentiment.

Positives

  • A director increasing their stake in the company could be seen as a positive signal.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates changes in beneficial ownership by a director of Clene Inc.

Key Dates

DateDescription
July 11, 2024Clene Inc. underwent a 1-for-20 reverse stock split.
September 30, 2024Alison Mosca acquired shares and warrants.
October 1, 2024Warrants become exercisable.
October 1, 2029Warrants expire.
October 02, 2024Date of signature of the form.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.